Opening Day: Actuate Therapeutics makes public debut - InvestingChannel

Opening Day: Actuate Therapeutics makes public debut

Actuate Therapeutics is the latest biotech to join Nasdaq, opening for trading at $9. 88 on Tuesday… To see the rest of the story go to thefly.com. (See Story Here):(https://www.thefly.com/permalinks/entry.php/id3970767/-Opening-Day-Actuate-Therapeutics-makes-public-debut)

Related posts

Advisors in Focus- January 6, 2021

Gavin Maguire

Advisors in Focus- February 15, 2021

Gavin Maguire

Advisors in Focus- February 22, 2021

Gavin Maguire

Advisors in Focus- February 28, 2021

Gavin Maguire

Advisors in Focus- March 18, 2021

Gavin Maguire

Advisors in Focus- March 21, 2021

Gavin Maguire